Literature DB >> 35379962

A split prime editor with untethered reverse transcriptase and circular RNA template.

Bin Liu1, Xiaolong Dong1, Haoyang Cheng1, Chunwei Zheng1, Zexiang Chen1, Tomás C Rodríguez1, Shun-Qing Liang1, Wen Xue2,3,4,5, Erik J Sontheimer6,7,8.   

Abstract

Delivery and optimization of prime editors (PEs) have been hampered by their large size and complexity. Although split versions of genome-editing tools can reduce construct size, they require special engineering to tether the binding and catalytic domains. Here we report a split PE (sPE) in which the Cas9 nickase (nCas9) remains untethered from the reverse transcriptase (RT). The sPE showed similar efficiencies in installing precise edits as the parental unsplit PE3 and no increase in insertion-deletion (indel) byproducts. Delivery of sPE to the mouse liver with hydrodynamic injection to modify β-catenin drove tumor formation with similar efficiency as PE3. Delivery with two adeno-associated virus (AAV) vectors corrected the disease-causing mutation in a mouse model of type I tyrosinemia. Similarly, prime editing guide RNAs (pegRNAs) can be split into a single guide RNA (sgRNA) and a circular RNA RT template to increase flexibility and stability. Compared to previous sPEs, ours lacks inteins, protein-protein affinity modules and nuclease-sensitive pegRNA extensions, which increase construct complexity and might reduce efficiency. Our modular system will facilitate the delivery and optimization of PEs.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35379962     DOI: 10.1038/s41587-022-01255-9

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   68.164


  2 in total

1.  Peptide fusion improves prime editing efficiency.

Authors:  Minja Velimirovic; Larissa C Zanetti; Max W Shen; James D Fife; Lin Lin; Minsun Cha; Ersin Akinci; Danielle Barnum; Tian Yu; Richard I Sherwood
Journal:  Nat Commun       Date:  2022-06-18       Impact factor: 17.694

Review 2.  New CRISPR Tools to Correct Pathogenic Mutations in Usher Syndrome.

Authors:  Lauren Major; Michelle E McClements; Robert E MacLaren
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.